Product Description
Doxorubicin hydrochloride injection, 2 mg/mL, is a prescription anthracycline chemotherapy medicine used in the treatment of various cancers. It is administered by experienced healthcare professionals as part of single-agent or combination chemotherapy regimens. The medicine works by interfering with the DNA of cancer cells, helping slow or stop their growth.
It is intended for hospital use and should only be administered in healthcare facilities equipped for chemotherapy treatment.
Instructions to Be Given to Patients
Patients receiving Doxorubicin Injection should be advised to do the following:
- Attend all scheduled treatment and follow-up appointments.
- Complete all blood tests requested by the oncologist.
- Inform the medical team immediately if fever, infection, or unusual bleeding develops.
- Maintain adequate hydration unless instructed otherwise.
- Report pain, redness, or swelling at the injection site.
- Inform healthcare providers about all medicines and supplements currently being taken.
- Avoid receiving live vaccines without medical advice.
- Follow dietary and supportive care recommendations provided by the oncology team.
Drug Interactions
Doxorubicin may interact with several medicines, including:
- Other chemotherapy medicines
- Immunosuppressive drugs
- Live vaccines
- Certain antibiotics
- Medicines affecting heart function
- Liver enzyme inhibitors or inducers
- Radiation therapy
- Blood-thinning medicines
Effects on Ability to Drive and Use Machines
Doxorubicin may cause fatigue, dizziness, weakness, or nausea in some patients. If these symptoms occur, patients should avoid:
- Driving vehicles
- Operating heavy machinery
- Performing tasks requiring full concentration
- Working at heights or in hazardous environments
Important Precautions
Before treatment, healthcare professionals should evaluate:
- Cardiac function
- Liver function
- Kidney function
- Complete blood count
- Previous chemotherapy exposure
- Existing infections
- Pregnancy or breastfeeding status
- History of allergic reactions
What Happens in Case of Overdose?
An overdose of doxorubicin is a medical emergency and requires immediate hospital management.
Possible complications may include:
- Severe bone marrow suppression
- Serious infections
- Excessive bleeding
- Severe inflammation of the mouth and digestive tract
- Cardiac toxicity
- Liver complications
- Increased risk of treatment-related toxicity
Frequently Asked Questions
1. What types of cancer is Doxorubicin Injection commonly used for what?
It is commonly included in chemotherapy protocols for breast cancer, ovarian cancer, bladder cancer, leukemias, lymphomas, sarcomas, and several other malignancies as determined by an oncologist.
2. Can doxorubicin be administered at home?
No. Doxorubicin injection should only be administered by trained healthcare professionals in hospitals or specialized oncology centers.
3. What should buyers verify before importing Doxorubicin?
International buyers should verify product registration requirements, GMP compliance, available export documentation, storage conditions, packaging specifications, and remaining shelf life before procurement.
4. What export documents are generally available?
Depending on manufacturer availability, documentation may include COA, batch COA, product specifications, manufacturing license, WHO-GMP certificate, certificate of origin, commercial invoice, and packing list.
5. Which strengths are commonly available?
Commercial presentations include 2 mg/mL, 10 mg, 20 mg, 50 mg, and 100 mg formulations depending on the manufacturer.
Chemotherapy Medicine Supplier:
United States, Washington, D.C.; United Kingdom, London; Germany, Berlin; France, Paris; Italy, Rome; Spain, Madrid; Netherlands, Amsterdam; Belgium, Brussels; Switzerland, Bern; Poland, Warsaw; Hungary, Budapest; Australia, Canberra; New Zealand, Wellington; Singapore; Malaysia, Kuala Lumpur; Indonesia, Jakarta; Vietnam, Hanoi; Philippines, Manila; Thailand, Bangkok. United Arab Emirates, Abu Dhabi; Saudi Arabia, Riyadh; Qatar, Doha; Oman, Muscat; Kuwait, Kuwait City; South Africa, Pretoria; Nigeria, Abuja; Peru, Lima; Argentina, Buenos Aires; Brazil, Brasília; Mexico, Mexico City; Chile, Santiago; Colombia, Bogotá
(A group of Ernest Pharmaceutical Pvt. Ltd.)
www.ernestimpex.com | www.ernestvision.com | www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com
📲 WhatsApp: +91 93599 02383 / https://wa.me/919359902383
